208 related articles for article (PubMed ID: 17249904)
21. Impact of deliveries on the office practice of family medicine.
Rodney WM; Hardison D; Rodney-Arnold K; McKenzie L
J Natl Med Assoc; 2006 Oct; 98(10):1685-90. PubMed ID: 17052062
[TBL] [Abstract][Full Text] [Related]
22. A randomized controlled study of weekly and biweekly dosing of epoetin alfa in CKD Patients with anemia.
Pergola PE; Gartenberg G; Fu M; Wolfson M; Rao S; Bowers P
Clin J Am Soc Nephrol; 2009 Nov; 4(11):1731-40. PubMed ID: 19808215
[TBL] [Abstract][Full Text] [Related]
23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
24. Analysis of costs associated with administration of intravenous single-drug therapies in metastatic breast cancer in a U.S. population.
Kruse GB; Amonkar MM; Smith G; Skonieczny DC; Stavrakas S
J Manag Care Pharm; 2008; 14(9):844-57. PubMed ID: 19006441
[TBL] [Abstract][Full Text] [Related]
25. The cost associated with administering risperidone long-acting injections in the Australian community.
Dalton A; Lambert T; Schrover R; Hertel J; Smith DK
BMC Health Serv Res; 2011 Sep; 11():236. PubMed ID: 21943060
[TBL] [Abstract][Full Text] [Related]
26. Administrative Costs Associated With Physician Billing and Insurance-Related Activities at an Academic Health Care System.
Tseng P; Kaplan RS; Richman BD; Shah MA; Schulman KA
JAMA; 2018 Feb; 319(7):691-697. PubMed ID: 29466590
[TBL] [Abstract][Full Text] [Related]
27. Assessment of the impact of weekly versus monthly erythropoiesis stimulating protein therapy on patients with CKD and their families.
Globe D; Glidden D; Hertel J; Thomas J; Ackerman M; Chidolue F; Blanco B; Borden A; Goss TF; Xu X; Kewalramani R
Nephrol Nurs J; 2007; 34(2):151-61. PubMed ID: 17486946
[TBL] [Abstract][Full Text] [Related]
28. Same-Day vs Different-Day Elective Upper and Lower Endoscopic Procedures by Setting.
Wang P; Hutfless SM; Shin EJ; Hartman C; Disney S; Fain CC; Bull-Henry KP; Daniels DK; Abdi T; Singh VK; Kalloo AN; Makary MA
JAMA Intern Med; 2019 Jul; 179(7):953-963. PubMed ID: 31081872
[TBL] [Abstract][Full Text] [Related]
29. Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.
Prosser LA; O'Brien MA; Molinari NA; Hohman KH; Nichol KL; Messonnier ML; Lieu TA
Pharmacoeconomics; 2008; 26(2):163-78. PubMed ID: 18198935
[TBL] [Abstract][Full Text] [Related]
30. Clinical and economic outcomes in Medicare beneficiaries with stage 3 or stage 4 chronic kidney disease and anemia: the role of intravenous iron therapy.
Knight TG; Ryan K; Schaefer CP; D'Sylva L; Durden ED
J Manag Care Pharm; 2010 Oct; 16(8):605-15. PubMed ID: 20866165
[TBL] [Abstract][Full Text] [Related]
31. Healthcare costs for abortions performed in ambulatory surgery centers vs office-based settings.
Leslie DL; Liu G; Jones BS; Roberts SCM
Am J Obstet Gynecol; 2020 Apr; 222(4):348.e1-348.e9. PubMed ID: 31629727
[TBL] [Abstract][Full Text] [Related]
32. Home Therapy to Reduce Office Visits for Patients with Chronic Kidney Disease and Anemia.
Riley MV; Vess J; Dumas BP
Nephrol Nurs J; 2017; 44(1):29-33. PubMed ID: 29237106
[TBL] [Abstract][Full Text] [Related]
33. Medical utilization associated with palivizumab compliance in a commercial and managed medicaid health plan.
Diehl JL; Daw JR; Coley KC; Rayburg R
J Manag Care Pharm; 2010; 16(1):23-31. PubMed ID: 20044844
[TBL] [Abstract][Full Text] [Related]
34. Parameters for successful monthly extended dosing of darbepoetin-alpha in patients undergoing hemodialysis.
Trachsler J; Glück Z; Dickenmann M; Gauthier T; Brünisholz M; Martin PY; Burnier M; Wahl C; Wüthrich RP
Clin Nephrol; 2009 Jun; 71(6):697-702. PubMed ID: 19473639
[TBL] [Abstract][Full Text] [Related]
35. An observational cohort study of extended dosing (once every 2 weeks or once monthly) regimens with darbepoetin alfa in patients with chronic kidney disease not on dialysis: the EXTEND study.
Galle JC; Claes K; Kiss I; Winearls CG; Herlitz H; Guerin A; Di Giulio S; Suranyi MG; Bridges I; Addison J; Farouk M
Nephrol Dial Transplant; 2012 Jun; 27(6):2303-11. PubMed ID: 22140136
[TBL] [Abstract][Full Text] [Related]
36. Development of an activity-based costing model to evaluate physician office practice profitability.
Dugel PU; Tong KB
Ophthalmology; 2011 Jan; 118(1):203-208.e1-3. PubMed ID: 20709400
[TBL] [Abstract][Full Text] [Related]
37. The comparative economic burden of mild, moderate, and severe fibromyalgia: results from a retrospective chart review and cross-sectional survey of working-age U.S. adults.
Chandran A; Schaefer C; Ryan K; Baik R; McNett M; Zlateva G
J Manag Care Pharm; 2012; 18(6):415-26. PubMed ID: 22839682
[TBL] [Abstract][Full Text] [Related]
38. Extended epoetin alfa dosing as maintenance treatment for the anemia of chronic kidney disease: the PROMPT study.
Provenzano R; Bhaduri S; Singh AK;
Clin Nephrol; 2005 Aug; 64(2):113-23. PubMed ID: 16114787
[TBL] [Abstract][Full Text] [Related]
39. The costs of caring for erectile dysfunction in a managed care setting: evidence from a large national claims database.
Sun P; Seftel A; Swindle R; Ye W; Pohl G
J Urol; 2005 Nov; 174(5):1948-52. PubMed ID: 16217364
[TBL] [Abstract][Full Text] [Related]
40. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
